Subscribe to the MAC Clinical Research Insights newsletter to keep up to date with expert insights and analysis. The first edition of the newsletter is already available and explores the question: can the placebo effect really be controlled in clinical trials? Read the article and subscribe here: https://lnkd.in/eHs6nPW5 #ClinicalResearch #CRO #Placebo #Insights #Newsletter
MAC Clinical Research’s Post
More Relevant Posts
-
During early study planning, determining how to run your #clinicalresearch—fully internally, or with a CRO—is a crucial decision. In our latest blog, we highlight considerations for both approaches as they relate to sponsors’ goals and internal capabilities. Read the blog: https://lnkd.in/esWEkBzX #cro #clinicaltrials #drugdevelopment
To view or add a comment, sign in
-
The future of clinical trials is inclusive, automated, and data-driven! 💫 I had the opportunity to speak with Newsweek and share details on Advanced Clinical’s recent global expansion, the importance of inclusivity in clinical trials, and predict upcoming challenges and successes. If you have a few minutes today, read the interview here: https://bit.ly/4cyn5Ub I’d love to know what your predictions are for clinical trials! #ClinicalResearch #CRO #StrategicResourcing
To view or add a comment, sign in
-
Today we celebrate all that has been accomplished thanks to clinical trials and the people behind them. Happy clinical trials day to all fellow trailblazers (or should we say trialblazers 😉) in clinical research! #ClinicalTrialsDay #CTD2024 #medicaldevices #expert #CRO #humanhealth #archerresearch
To view or add a comment, sign in
-
When evaluating proposals from Contract Research Organizations (CROs) for phase 1 trials, it's crucial to look for key elements that ensure a successful partnership. By focusing on these must-haves, you can make informed decisions that enhance the efficiency and effectiveness of your clinical research. To learn more about partnering with the right phase 1 CRO, check out this article: https://hubs.li/Q02ZvcL70 #ClinicalResearch #CRO #ClinicalTrials #Phase1
To view or add a comment, sign in
-
Southern Star Research guides you and your product through the complexities of running a clinical trial. Our people are leaders in their field and can help you accelerate your study and achieve optimal results. #CRO #ClinicalTrials #MedicalTrials #ClinicalResearch
To view or add a comment, sign in
-
Are you ready to #LevelUp your clinical trial? Our team’s extensive expertise is here to take your research to the next level. We specialize in turning even the toughest trials into success stories. Reach out to us at info@StirisResearch.com or learn more about our experience at www.stirisresearch.com. #ClinicalResearch #ClinicalTrials #CRO #StirisResearch
To view or add a comment, sign in
-
Oncology or orphan indication? Got it. Phase II or phase III? No problem. 👍 When you work with Siron Clinical, you access our decades of experience across therapeutic areas and trial types. Find out how we can support your clinical trial: https://buff.ly/2JSUFI1 #clinicaltrials #CRO #clinicalresearch #projectmanagement #consultants
To view or add a comment, sign in
-
Expedite your #clinicaltrial kit request with #QPS. Whether you require a few kits for a small study or many, complex kits for a large multi-site #clinicalresearch study. Visit https://shorturl.at/hzFT0 to receive a quote or email us at info@qps.com. #CRO #drugdevelopment
Clinical Trials Kits - QPS: Custom-Built Research
qps.com
To view or add a comment, sign in
-
A snippet from our most recent webinar with Habitual on best practices for executing #consumerhealth trials, where Meri Beckwith talks #patientengagement tactics that have resulted in 95% adherence across our studies. Watch the full webinar: https://lnkd.in/dKptDN7V #consumerhealthresearch #patientretention #clinicaltrials #cro
To view or add a comment, sign in
-
🚀 Exciting Milestone: SR750 Enrolls First Patient in Phase II Trial for Trigeminal Neuralgia! 🧬 We are thrilled to announce that SR750, SIMR Biotech’s innovative treatment for trigeminal neuralgia (TGN), has successfully enrolled its first patient in the Phase II clinical trial in China! This significant step forward brings us closer to addressing the unmet needs of patients suffering from this debilitating condition. 🔬 Why SR750 Matters SR750 is a first-in-class candidate specifically designed to tackle peripheral neuropathic pain with a novel mechanism of action. With orphan drug designation from the FDA, SR750 aims to provide a new therapeutic option for TGN patients who have limited treatment choices. 📈 What’s Next? The ongoing clinical trial will explore the optimal dosing and efficacy of SR750 in TGN patients, marking a critical stage in our journey toward providing new hope for those affected by this severe chronic pain condition. A big thank you to our incredible team and clinical partners who continue to drive this mission forward! Stay tuned for more updates as we continue to make strides in TGN treatment. #SIMRBiotech #ClinicalTrials #InnovationInHealth #TrigeminalNeuralgia #NeuropathicPain #SR750 #Biotech
To view or add a comment, sign in
13,670 followers
More from this author
-
Are Decentralised Trials Really the Future of Clinical Research?
MAC Clinical Research 1w -
Will psychedelic-assisted therapy gain acceptance as a legitimate treatment option?
MAC Clinical Research 3mo -
Why participant recruitment remains the biggest challenge in clinical trials
MAC Clinical Research 6mo